| Expression pattern: |
UP |
| Associated gene: |
WNT3A |
| Associated microRNA: |
miR-361-3p |
| Biological function: |
Promotes RB cell proliferation, migration, invasion, cell cycle progression, stemness-associated marker expression, and tumor growth in vivo. |
| Molecular mechanism: |
circDHDDS acts as a miR-361-3p sponge to regulate WNT3A expression, thereby promoting RB development. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); stemness (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; Western Blot; In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
Potential therapeutic or functional target perspective for RB; diagnostic value was suggested as requiring future verification. |
| Description: |
circDHDDS is up-regulated in retinoblastoma tissues and cells. It promotes RB cell proliferation, migration, invasion, cell cycle progression, stemness-related marker expression, and xenograft tumor growth by sponging miR-361-3p and increasing WNT3A expression. |
| Confidence score: |
0.7416 |